Saige Brain

Assess and monitor neurodegenerative changes with quantitative and reference data.

Empower your workflow with Brain Health, our AI-powered clinical imaging solution for brain atrophy quantification and white matter hyperintensities (WMH) detection.

Brain Health is FDA-cleared, CE-marked and integrates seamlessly into your workflow. Examination results, reports, and segmentations are exported directly to the PACS. You can opt for on site or cloud deployment to fit your needs.

Capabilities

Brain Health

Clinical features

Brain atrophy analysis

Brain Health supports the assessment and monitoring of brain atrophy by automatically segmenting and measuring brain structures on scans. It provides single-time-point and longitudinal analyses.

WMH analysis

Brain Health offers editable single-time-point and automated longitudinal WMH analyses to support single examinations and tracking of lesion development.

Comprehensive reports

Assess and monitor your patient’s condition with our comprehensive reports. Brain Health generates a report per analysis, including patient and study data, a quantitative table, reference centile curves, and key images.

Brain Health (Quantib® ND in Europe) is manufactured for DeepHealth by Quantib B.V. For clearance and availability in your geography of all functionalities listed, please contact us.

Saige Brain (Quantib® ND in Europe) is manufactured for DeepHealth by Quantib B.V. For clearance and availability in your geography of all functionalities listed, please contact us.

Benefit from automated segmentations of brain structures and WMH detection.

Explore our products

Enterprise Imaging

Foundational informatics to orchestrate workflow.

eRAD

Operational efficiency with AI.

Population Health

Clinical AI-powered tools.

Learn more

  • Case Study

    “AI provides extra information”: Brain Health at Erasmus MC

    DeepHealth

    With Meike Vernooij M.D., Neuroradiologist at the Alzheimercentrum Erasmus MC and Professor of Population Imaging at Erasmus MC

  • Scientific Publication

    Combining semi‑quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of frontotemporal dementia: an added value for clinical practise?

    Sonia Francesca Calloni, Paolo Quintiliano Vezzulli, Antonella Castellano, Riccardo Leone, Silvia Basaia, Almar von Loon, Edoardo Gioele Spinelli, Giuseppe Magnani, Francesca Caso, Federica Agosta, Massimo Filippi & Andrea Falini

    DIAGNOSTIC NEURORADIOLOGY March 3, 2023

  • Scientific Publication

    Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia

    Jackie M. Poos, Leonie D. M. Grandpierre, Emma L. van der Ende, Jessica L. Panman, Janne M. Papma, Harro Seelaar, Esther van den Berg, Ronald van 't Klooster, Esther Bron, Rebecca Steketee, Meike W. Vernooij, Yolande A. L. Pijnenburg, Serge A. R. B. Rombouts, John van Swieten, Lize C. Jiskoot

    NEUROLOGY October 26, 2022

  • Scientific Publication

    Comparing two artificial intelligence software packages for normative brain volumetry in memory clinic imaging

    Lara A. M. Zaki, Meike W. Vernooij, Marion Smits, Christine Tolman, Janne M. Papma, Jacob J. Visser & Rebecca M. E. Steketee

    NEURORADIOLOGY January 15, 2022